Company

Neuron Guard s.r.l.

Neuron Guard s.r.l. makes the CB240_AURORA, a portable device for targeted cooling of the brain in acute brain injury patients.

About

Neuron Guard develops portable medical devices for targeted temperature management of the brain, aimed at acute brain injuries such as strokes and traumatic brain injuries. Its flagship CB240_AURORA is sold mainly to hospitals and emergency medical services. Founded in 2013 and based in Modena, Italy, the company is at the Seed stage, with CEO Enrico Giuliani. Its latest funding was a EUR 0.65 mn venture debt round led by CDP Venture Capital in November 2021.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in